Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Excellent product, fast delivery It has made a difference in how I feel and I have lost weight
Further experimentation also suggests that BPC-157 may speed up bone healing in vivo
July 23, 2026: Pharmacy Compounding Advisory Committee meeting The FDA has scheduled a Pharmacy Compounding Advisory Committee (PCAC) meeting for July 23, 2026 to evaluate BPC-157 and TB-500 (free base and acetate forms), along with KPV and MOTs-C
Multi-Functional Regenerative Peptide Stem Cell Mobilisation & Scar Reduction (PubMed, 2012) A comprehensive review of TB4s biological properties published in Expert Opinion on Biological Therapy confirmed that TB4 is released by platelets, macrophages, and multiple cell types following injury, where it protects cells and tissues from further damage while reducing apoptosis, inflammation, and microbial growth
Application of TB-500+BPC-157 PEN in research analyses TB-500 + BPC-157 PEN is used in research into tissue response mechanisms, cell migration, the actin cytoskeleton, fibroblast activity, angiogenesis and extracellular matrix remodelling
BPC-157 is not an FDA-approved drug, which means it is not available as a retail prescription product
